Physician profile
Anna Ballard
NPI 1700031754
$5,856.25
in general payments reported to CMS, 2019-2025
13 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,474 · 2020: $15.89 · 2021: $513 · 2022: $1,285 · 2023: $14.70 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,277 · Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,276.64 |
| Food and Beverage | $292.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $2,715.61 | 2022-2025 | Portfolio, Apex 3d |
| Wright Medical Technology, INC. | $2,254.64 | 2019 | |
| Acumed LLC | $512.84 | 2021 | |
| Integra Lifesciences Corporation | $184.56 | 2019 | |
| Amgen INC. | $53.56 | 2019-2025 | Evenity |
| Treace Medical Concepts, INC. | $30.57 | 2022 | |
| Solventum Corporation | $25.71 | 2025 | Activ.A.C. |
| Hologic Sales and Service, LLC | $19.37 | 2022 | |
| Insulet Corporation | $15.89 | 2020 | |
| Smith+Nephew, INC. | $14.70 | 2023 | Collagenase Santyl |
| Bioventus LLC | $13.63 | 2022 | |
| Orthofix Medical, INC. | $8.37 | 2025 | Physio-Stim |
| Kerecis Limited | $6.80 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Ballard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.